IDEXX LABORATORIES INC /DE
IDXX· Nasdaq· In Vitro & In Vivo Diagnostic Substances
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- 24.6%
- ROIC, 5 yr avg
- 53.3%
- Revenue, 5 yr CAGR
- +9.7%
We record prices for the companies we cover; IDXX is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 81.0M
- Revenue
- $4.3B
- Free cash flow
- $1.1B
- Owner earnings
- $997.1M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- 61.8%
- Operating
- 31.6%
- Net
- 24.6%
- Free cash flow
- 24.6%
- Owner earnings
- 23.2%
- Stock pay
- 1.4%
Returns
- ROIC, FY2025
- 58.0%
- ROIC, 5 yr avg
- 53.3%
- ROE, FY2025
- 66.0%
- ROE, 5 yr avg
- 79.6%
Growth (CAGR)
- Revenue, 3 yr
- 8.5%
- Revenue, 5 yr
- 9.7%
- Revenue, 9 yr
- 10.3%
- Diluted EPS, 3 yr
- 17.7%
- Diluted EPS, 5 yr
- 14.3%
- Diluted EPS, 9 yr
- 20.5%
- Free cash flow, 3 yr
- 38.9%
- Free cash flow, 5 yr
- 14.3%
- Free cash flow, 9 yr
- 16.2%
Financial health · FY2025
- Cash and investments
- $180.1M
- Total debt
- $449.8M
- Net debt
- $269.8M
- Debt/Equity
- 0.3x
- Debt/FCF
- 0.4x
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- -1.3%
Financials: ten years from the 10-Ks
Revenue
$4.3B
+10.3% a year over 9 years
FY2016FY2025
Margins
Gross61.8%Operating31.6%Net24.6%
FY2025
FY2016FY2025
Free cash flow and owner earnings
Free cash flow$1.1BOwner earnings$997.1M
Free cash flow +16.2% a year
FY2016FY2025
Diluted shares
81.0M
-10.8% over 9 years, net buybacks
FY2016FY2025
Return on invested capital
58.0%
FY2025
FY2016FY2025
Net debt (below zero)
-$269.8M
$269.8M more debt than cash
FY2016FY2025
Every figure, year by year
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| The business | ||||||||||
| Revenue | $1.8B | $2.0B | $2.2B | $2.4B | $2.7B | $3.2B | $3.4B | $3.7B | $3.9B | $4.3B |
| Revenue growth | 10.8% | 10.9% | 12.4% | 8.8% | 12.5% | 18.8% | 4.7% | 8.7% | 6.5% | 10.4% |
| Gross margin | 54.9% | 55.7% | 56.1% | 56.7% | 58.0% | 58.8% | 59.5% | 59.8% | 61.0% | 61.8% |
| Operating margin | 19.7% | 21.0% | 22.2% | 23.0% | 25.7% | 29.0% | 26.7% | 30.0% | 29.0% | 31.6% |
| Net income | $222.0M | $263.1M | $377.0M | $427.7M | $581.8M | $744.8M | $679.1M | $845.0M | $887.9M | $1.1B |
| Net margin | 12.5% | 13.4% | 17.0% | 17.8% | 21.5% | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% |
| Diluted EPS | $2.44 | $2.94 | $4.26 | $4.89 | $6.71 | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 |
| Return on invested capital? | 258.4% | 354.2% | 86.4% | 57.6% | 52.8% | 55.1% | 56.1% | 50.5% | 46.9% | 58.0% |
| Cash | ||||||||||
| Operating cash flow | $338.9M | $373.3M | $400.1M | $459.2M | $648.1M | $755.5M | $543.0M | $906.5M | $929.0M | $1.2B |
| Capital expenditure | $64.8M | $74.4M | $115.8M | $155.0M | $107.0M | $119.5M | $148.8M | $133.6M | $120.9M | $124.7M |
| Free cash flow | $274.2M | $298.9M | $284.3M | $304.2M | $541.1M | $636.0M | $394.1M | $772.9M | $808.1M | $1.1B |
| Stock-based compensation | $19.9M | $23.5M | $25.2M | $39.3M | $31.0M | $37.8M | $49.8M | $59.7M | $60.3M | $60.0M |
| Owner earnings? | $254.3M | $275.4M | $259.2M | $264.9M | $510.2M | $598.2M | $344.4M | $713.1M | $747.8M | $997.1M |
| Free cash flow per share | $3.02 | $3.34 | $3.21 | $3.47 | $6.24 | $7.35 | $4.66 | $9.20 | $9.71 | $13.05 |
| Capital allocation | ||||||||||
| Dividends paid | – | – | – | – | – | – | – | – | – | – |
| Share repurchases | $304.1M | $282.6M | $369.3M | $301.7M | $182.8M | $746.8M | $819.7M | $71.9M | $837.0M | $1.2B |
| Diluted shares | 90.9M | 89.6M | 88.5M | 87.5M | 86.7M | 86.6M | 84.6M | 84.0M | 83.2M | 81.0M |
| Share count change? | -3.0% | -1.4% | -1.2% | -1.0% | -0.9% | -0.2% | -2.3% | -0.7% | -0.9% | -2.7% |
| Balance sheet | ||||||||||
| Cash and equivalents | $154.9M | $187.7M | $123.8M | $90.3M | $383.9M | $144.5M | $112.5M | $453.9M | $288.3M | $180.1M |
| Short-term investments | $236.9M | $284.3M | $0 | – | – | – | – | – | – | – |
| Total debt | $593.7M | $606.6M | $601.8M | $698.9M | $908.5M | $850.2M | $769.4M | $697.9M | $617.6M | $449.8M |
| Net debt | $201.8M | $134.7M | $478.0M | $608.6M | $524.6M | $705.7M | $656.8M | $243.9M | $329.3M | $269.8M |
| Shareholders' equity | -$108.4M | -$54.1M | -$9.5M | $177.5M | $632.1M | $690.0M | $608.7M | $1.5B | $1.6B | $1.6B |
Latest filings
| 2026-08-04 | 10-Q | Quarterly report |
| 2026-08-04 | 8-K | Earnings release |
| 2026-05-05 | 10-Q | Quarterly report |
| 2026-05-05 | 8-K | Earnings release |
| 2026-03-27 | DEF 14A | Proxy statement |
| 2026-02-20 | 10-K | Annual report |
| 2026-02-02 | 8-K | Earnings release |
| 2025-11-03 | 10-Q | Quarterly report |
| 2025-11-03 | 8-K | Earnings release |
| 2025-08-04 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
